PTJ
ABCL icon

Paul Tudor Jones’s AbCellera Biologics ABCL Stock Holding History

Paul Tudor Jones’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.2M Sell
2,063,191
-210,298
-9% -$1.03M 0.02% 586
2026
Q1 		$7.93M Buy
2,273,489
+477,479
+27% +$1.72M 0.01% 874
2025
Q4 		$6.14M Buy
1,796,010
+1,065,888
+146% +$4.76M 0.01% 1031
2025
Q3 		$3.67M Buy
+730,122
New +$3.22M 0.01% 1402
2024
Q3 		– Sell
-236,649
Closed -$700K – 2642
2024
Q2 		$700K Buy
236,649
+145,915
+161% +$552K ﹤0.01% 1651
2024
Q1 		$411K Buy
+90,734
New +$463K ﹤0.01% 1733
2023
Q4 		– Sell
-20,105
Closed -$92.5K – 2297
2023
Q3 		$92.5K Buy
20,105
+1,858
+10% +$11.3K ﹤0.01% 2154
2023
Q2 		$118K Buy
18,247
+175
+1% +$1.19K ﹤0.01% 2285
2023
Q1 		$136K Buy
18,072
+2,424
+15% +$22K ﹤0.01% 2226
2022
Q4 		$159K Buy
15,648
+402
+3% +$4.64K ﹤0.01% 2169
2022
Q3 		$151K Buy
15,246
+4,977
+48% +$54.6K ﹤0.01% 2125
2022
Q2 		$109K Sell
10,269
-10,840
-51% -$91.8K ﹤0.01% 1912
2022
Q1 		$206K Buy
+21,109
New +$200K ﹤0.01% 1758
2021
Q4 		– Sell
-15,121
Closed -$303K – 2310
2021
Q3 		$303K Sell
15,121
-64,603
-81% -$1.14M ﹤0.01% 2029
2021
Q2 		$1.75M Buy
+79,724
New +$2.2M 0.03% 623

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Paul Tudor Jones's ABCL Position: Q2 2026 in Review

Paul Tudor Jones reduced its AbCellera Biologics (ABCL) stake by 9.3% in Q2 2026, selling an estimated $1.03M and leaving 2,063,191 shares worth $16.2M. The position accounts for 0.02% of the portfolio, ranked #586.

Paul Tudor Jones first reported a position in ABCL in Q2 2021 and has held it in 15 quarters since. 151 funds tracked by Wall St. Rank hold ABCL as of Q2 2026.

  • Paul Tudor Jones held 2,063,191 shares of AbCellera Biologics worth $16.2M as of Q2 2026.
  • Paul Tudor Jones sold 210,298 AbCellera Biologics shares in Q2 2026, an estimated $1.03M.
  • AbCellera Biologics made up 0.02% of Paul Tudor Jones's portfolio in Q2 2026, its #586 holding.
  • Paul Tudor Jones first reported a position in AbCellera Biologics in Q2 2021 and has held it in 15 quarters since.
  • 151 funds tracked by Wall St. Rank held AbCellera Biologics as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.